The selection was either based on significant regulation among the list of CEC-associated genes (Figure 4C), relation to liver fibrosis [Gata4, Myc, platelet-derived growth factor subunit B (Pdgfb)] (Winkler et al., 2021), or established LSEC angiocrine factors. The gene discussed is GATA4; the disease is Hepatic fibrosis.